# ENANTA PHARMACEUTICALS INC (ENTA) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from ENANTA PHARMACEUTICALS INC's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ENTA/mda/fy2025/): filed 2025-11-19; accession 0001193125-25-288121 (https://www.sec.gov/Archives/edgar/data/1177648/000119312525288121/enta-20250930.htm); latest 10-K
- [FY 2024 MD&A](/company/ENTA/mda/fy2024/): filed 2024-11-27; accession 0000950170-24-131260 (https://www.sec.gov/Archives/edgar/data/1177648/000095017024131260/enta-20240930.htm)
- [FY 2023 MD&A](/company/ENTA/mda/fy2023/): filed 2023-11-22; accession 0000950170-23-065884 (https://www.sec.gov/Archives/edgar/data/1177648/000095017023065884/enta-20230930.htm)
- [FY 2022 MD&A](/company/ENTA/mda/fy2022/): filed 2022-11-23; accession 0000950170-22-025667 (https://www.sec.gov/Archives/edgar/data/1177648/000095017022025667/enta-20220930.htm)
- [FY 2021 MD&A](/company/ENTA/mda/fy2021/): filed 2021-11-24; accession 0000950170-21-004895 (https://www.sec.gov/Archives/edgar/data/1177648/000095017021004895/enta-20210930.htm)

Back to /company/ENTA/